TECN Tecan Group AG

289.30USD243.80 CHF · SWX+2.87%Mkt Cap: 3.56B USDP/E: —

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Busi…

Institutional holders10 on file

Key Statistics

Company
Market Cap3.56B USD
Enterprise Value3.55B USD
Revenue (TTM)1.03B USD
Gross Profit368.85M USD
Net Income (TTM)-131.30M USD
Revenue/Share82.61 USD
Last Price289.30 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0012100191
Valuation
P/E (Trailing)—
P/E (Forward)30.44
PEG1.71
EV/EBITDA39.36
EV/Revenue3.44
P/S3.45
P/B2.69
EPS (TTM)-10.69 USD
EPS (Forward)9.50 USD
52W Range
131.2480% of range329.88
52W High329.88 USD
52W Low131.24 USD
Profitability
Gross Margin35.22%
Oper. Margin4.89%
EBITDA Margin8.74%
Profit Margin-12.54%
ROE-9.61%
ROA-6.52%
ROIC4.54%
ROCE3.41%
Growth
Revenue Growth-2.70%
Earnings Growth-29.80%
Cash Flow & Leverage
Operating CF163.73M USD
CapEx (TTM)41.89M USD
FCF Margin5.74%
FCF Yield1.66%
Net Debt-12.06M USD
Net Debt/EBITDA-0.13
Net Debt/FCF-0.20
Balance Sheet
Debt/Equity0.19
Current Ratio2.32
Quick Ratio1.50
Book Value/Sh107.64 USD
Cash/Share21.62 USD
Dividends
Fwd Div Rate3.56 USD
Trail. Div Rate3.56 USD
Div. Yield1.27%
5Y Avg Yield1.01%
Payout Ratio60.61%
Ex-Div DateApr 17, 2026
Pay DateApr 16, 2025
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)264.29 USD
Upside (mean)-8.6%
Target Range190.81 USD – 373.79 USD
190.81-8.6% to mean373.79
# Analysts8
Ownership
Shares Out.12.32M
Float12.27M
Insiders0.43%
Institutions71.08%
Technical
SMA 50280.90 (+3.0%)
SMA 200207.45 (+39.5%)
Beta1.01
S&P 52W Chg12.00%
Avg Vol (30d)67.14K
Avg Vol (10d)65.57K
Technical Indicators
RSI (14)49.1
MACD1.7667
MACD Signal4.5545
MACD Hist.-2.7878
BB Upper314.46 USD
BB Middle295.66 USD
BB Lower276.86 USD
BB Width12.72%
ATR (14)11.32 USD
Vol Ratio (20d)0.72x

About Tecan Group (SWX: TECN)

›

Tecan Group (SWX: TECN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 3,000 employees.

The shares were at 243.80 CHF on 19 November 2026, up 79.8% over 52 weeks. Its 52-week range is 110.60 CHF to 278.00 CHF: the price is 12.3% below the high and 120.4% above the low.

Its market capitalisation is 3.00B CHF. It pays a dividend yielding 1.27% (it pays out 61% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Tecan Group reports return on equity of -9.6%, an operating margin of 4.9% and revenue down 2.7% year over year.

It holds more cash than debt, a net cash position of 10.16M CHF. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 8 analysts cover the stock, with an average rating of Buy; their mean price target of 222.72 CHF is 8.6% below the current price. The next earnings report is expected on 10 March 2027.